Vanguard Group Inc Care Dx, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,834,073 shares of CDNA stock, worth $82.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,834,073
Previous 4,859,732
0.53%
Holding current value
$82.6 Million
Previous $104 Million
17.53%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CDNA
# of Institutions
230Shares Held
56.9MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$90.3 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$45.6 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$42.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$40.1 Million0.45% of portfolio
-
Bamco Inc New York, NY2.19MShares$37.4 Million0.12% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $913M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...